<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-BFA-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Burkina Faso (le): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Burkina Faso: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-44001" role="4" type="40">
   <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
  </participating-org>
  <participating-org ref="US-EIN-91-1157127" role="4">
   <narrative xml:lang="EN">PATH</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Burkina Faso</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="BF" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="BF" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Ouagadougou</narrative>
   </name>
   <administrative code="BF" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>12.36423 -1.53834</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1682228</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">3049307</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1902246</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">175533</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="BFAPEF-TCA-CDC FOUND2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">313148</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-IBRD2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-PATH2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">26303</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">11127</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">475740</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">655910</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-AMP2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">402356</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-CDC FOUND2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">438304</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-IBRD2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-PATH2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">48095</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">33951</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">873720</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1052880</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-AMP2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">575402</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-CDC FOUND2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">92400</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-PATH2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">100443</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">42851</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">550800</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">540350</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-AMP2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">73899</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="BFAPEF-TCA-PATH2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">101634</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000520">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-25"></transaction-date>
   <value currency="USD" value-date="2020-02-25">57422</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000862">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">28711</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002736">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">28711</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">6704</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002890">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-13"></transaction-date>
   <value currency="USD" value-date="2020-07-13">57422</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003961">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-29"></transaction-date>
   <value currency="USD" value-date="2020-09-29">28711</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003964">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-20"></transaction-date>
   <value currency="USD" value-date="2020-10-20">12634</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004595">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-17"></transaction-date>
   <value currency="USD" value-date="2020-11-17">28711</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005157">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-08"></transaction-date>
   <value currency="USD" value-date="2020-12-08">35100</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-64213</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">64213</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000067">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-12"></transaction-date>
   <value currency="USD" value-date="2021-01-12">14702</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000068">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-13"></transaction-date>
   <value currency="USD" value-date="2021-01-13">28711</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001990">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-04"></transaction-date>
   <value currency="USD" value-date="2021-05-04">57358</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001458">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-10"></transaction-date>
   <value currency="USD" value-date="2021-05-10">13197</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003063">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">1550</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003092">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-12"></transaction-date>
   <value currency="USD" value-date="2021-07-12">15671</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006226">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-17"></transaction-date>
   <value currency="USD" value-date="2021-11-17">26497</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006227">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-17"></transaction-date>
   <value currency="USD" value-date="2021-11-17">28679</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006376">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-24"></transaction-date>
   <value currency="USD" value-date="2021-11-24">11719</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006374">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-24"></transaction-date>
   <value currency="USD" value-date="2021-11-24">59848</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006792">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-06"></transaction-date>
   <value currency="USD" value-date="2021-12-06">25847</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006793">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-06"></transaction-date>
   <value currency="USD" value-date="2021-12-06">28679</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-AMP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000855">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">313147</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">438304</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002631">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-08"></transaction-date>
   <value currency="USD" value-date="2021-06-08">92400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001124">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001342">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-06"></transaction-date>
   <value currency="USD" value-date="2020-04-06">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">26303</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001178">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-14"></transaction-date>
   <value currency="USD" value-date="2020-05-14">25000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002734">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">23095</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-91-1157127">
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">9845</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-664</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">15951</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-6851</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">6851</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">525</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">1838</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000856">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">475740</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">457920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">415800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">550800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000857">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">655910</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">654840</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">398040</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">540350</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-burkina-faso-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Burkina Faso 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-burkina-faso-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Burkina Faso 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-burkina-faso-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Burkina Faso 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-burkina-faso-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Burkina Faso 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-burkina-faso-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Burkina Faso 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-burkina-faso-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Burkina Faso 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-burkina-faso-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Burkina Faso 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-burkina-faso-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Burkina Faso 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-BFA" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Initation of surveillance</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assessment of impact and effectiveness of Rotasiil in Burkina Faso">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Active rotavirus surveillance has been initiated and is ongoing in Burkina Faso.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les personnels PEV conduisent correctement le monitorage des chambres froides &#xE0; distance.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre du monitorage des chambres froides &#xE0; distance.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Activite annulee</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre du monitorage des chambres froides &#xE0; distance.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Activite annulee</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% de tests de calibrage et d&apos;&#xE9;talonnage sont correctement r&#xE9;alis&#xE9;s.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les capacit&#xE9;s du personnel PEV dans la r&#xE9;alisation des tests de calibrage/&#xE9;talonnage des chambres froides du d&#xE9;p&#xF4;t de la DPV, des r&#xE9;gions et des v&#xE9;hicules r&#xE9;frig&#xE9;r&#xE9;s.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Cette activite a ete annulee et ne devrait plus etre dans ce TCA.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les capacit&#xE9;s du personnel PEV dans la r&#xE9;alisation des tests de calibrage/&#xE9;talonnage des chambres froides du d&#xE9;p&#xF4;t de la DPV, des r&#xE9;gions et des v&#xE9;hicules r&#xE9;frig&#xE9;r&#xE9;s.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Cette activite a ete annulee et ne devrait plus etre dans ce TCA.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des ECF solaires livr&#xE9;s sont install&#xE9;s, fonctionnels et correctement utilis&#xE9;s.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui au suivi de l?installation et du fonctionnement des ECF solaires dans les formations sanitaires.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">L&apos; installation de 310 ECF HTCD solaires a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e par la societ&#xE9; GPS (Representant local de Haier). Ces ECF ont &#xE9;t&#xE9; achet&#xE9;s par l&apos;UNICEF sur financement de la Banque Mondiale et de GAVI/RSS3.
Une formation des utilisateurs &#xE0; savoir de 620 agents de sant&#xE9; (310 infirmiers chefs de poste et 310 responsables PEV) des differents CSPS a &#xE9;t&#xE9; egalement r&#xE9;alis&#xE9;e au cours de l&apos;installation par les techniciens. La formation a port&#xE9; sur les consignes d&apos;utilisation et la maintenance pr&#xE9;ventive de ces nouveaux ECF. 
Deux (02) consultants nationaux ont ete recrut&#xE9;s pour appuy&#xE9;s le minist&#xE8;re dans le suivi du d&#xE9;ploiement et l&apos;installation des ECF. Cependant d&apos;autres acquisitions sont toujours en cours grace &#xE0; l&apos;appui de Gavi, du m&#xE9;canisme COVAX et de l&apos;UNICEF. L&apos;analyse technique des offres pour le recrutement d&apos;un prestataire local pour l&apos;installation de 259 ECF est en cours.
 
* Module de formation des agents de sant&#xE9;
** Rapports des reunions du PMT</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui au suivi de l?installation et du fonctionnement des ECF solaires dans les formations sanitaires.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">L&apos; installation de 310 ECF HTCD solaires a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e par la societ&#xE9; GPS (Representant local de Haier). Ces ECF ont &#xE9;t&#xE9; achet&#xE9;s par l&apos;UNICEF sur financement de la Banque Mondiale et de GAVI/RSS3.
Une formation des utilisateurs &#xE0; savoir de 620 agents de sant&#xE9; (310 infirmiers chefs de poste et 310 responsables PEV) des differents CSPS a &#xE9;t&#xE9; egalement r&#xE9;alis&#xE9;e au cours de l&apos;installation par les techniciens. La formation a port&#xE9; sur les consignes d&apos;utilisation et la maintenance pr&#xE9;ventive de ces nouveaux ECF. 
Deux (02) consultants nationaux ont ete recrut&#xE9;s pour appuy&#xE9;s le minist&#xE8;re dans le suivi du d&#xE9;ploiement et l&apos;installation des ECF. Cependant d&apos;autres acquisitions sont toujours en cours grace &#xE0; l&apos;appui de Gavi, du m&#xE9;canisme COVAX et de l&apos;UNICEF. L&apos;analyse technique des offres pour le recrutement d&apos;un prestataire local pour l&apos;installation de 259 ECF est en cours.
 
* Module de formation des agents de sant&#xE9;
** Rapports des reunions du PMT</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documentation disponible sur 20 membres GTCV form&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les capacit&#xE9;s de 20 membres du GTCV-Burkina en mati&#xE8;re d?&#xE9;laboration de notes de recommandations bas&#xE9;es sur des donn&#xE9;es factuelles">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; en cours de r&#xE9;alisation. Les termes de r&#xE9;f&#xE9;rence ont &#xE9;t&#xE9; &#xE9;labor&#xE9;. L?identification des formateurs est en cours. La formation se tiendra d&#xE8;s la disponibilit&#xE9; des membres du GTCV.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les capacit&#xE9;s de 20 membres du GTCV-Burkina en mati&#xE8;re d?&#xE9;laboration de notes de recommandations bas&#xE9;es sur des donn&#xE9;es factuelles">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; en cours de r&#xE9;alisation. Les termes de r&#xE9;f&#xE9;rence ont &#xE9;t&#xE9; &#xE9;labor&#xE9;. L?identification des formateurs est en cours. La formation se tiendra d&#xE8;s la disponibilit&#xE9; des membres du GTCV.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">la documentation sur 20 m&#xE9;decins form&#xE9;s des zone de conflit est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les competences de 20 nouveaux medecins chefs des zones &#xE0; securit&#xE9; pr&#xE9;caire sur la gestion du PEV en situation d&apos;urgence humanitaire">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Cette activit&#xE9; est en cours les termes de r&#xE9;f&#xE9;rence de la formation ont &#xE9;t&#xE9; &#xE9;labor&#xE9;s. La formation qui avait &#xE9;t&#xE9; planifi&#xE9; au mois de mars 2021 n?a pas se tenir. Les modules de formation sont en cours d?&#xE9;laboration. La formation se tiendra d&#xE8;s que les modules seront disponibles.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les competences de 20 nouveaux medecins chefs des zones &#xE0; securit&#xE9; pr&#xE9;caire sur la gestion du PEV en situation d&apos;urgence humanitaire">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Cette activit&#xE9; est en cours les termes de r&#xE9;f&#xE9;rence de la formation ont &#xE9;t&#xE9; &#xE9;labor&#xE9;s. La formation qui avait &#xE9;t&#xE9; planifi&#xE9; au mois de mars 2021 n?a pas se tenir. Les modules de formation sont en cours d?&#xE9;laboration. La formation se tiendra d&#xE8;s que les modules seront disponibles.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Directive valid&#xE9; et dissemin&#xE9; dans les 70 districts sanitaires</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;elaboration et la mise en ?uvre de la directive nationale de vaccination au cours de la deuxi&#xE8;me ann&#xE9;e de vie, la strategie urbaine , les OMV et les zones de conflit">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les directives pour la vaccination dans les zones d?ins&#xE9;curit&#xE9; ont &#xE9;t&#xE9; &#xE9;labor&#xE9;es et valid&#xE9;es par le CCIA. Il est pr&#xE9;vu la formation des acteurs sur ces directives en septembre 2021. Les directives de la vaccination au cours de la deuxi&#xE8;me ann&#xE9;e de vie sont en cours avec l?&#xE9;laboration des termes de r&#xE9;f&#xE9;rences</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;elaboration et la mise en ?uvre de la directive nationale de vaccination au cours de la deuxi&#xE8;me ann&#xE9;e de vie, la strategie urbaine , les OMV et les zones de conflit">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les directives pour la vaccination dans les zones d?ins&#xE9;curit&#xE9; ont &#xE9;t&#xE9; &#xE9;labor&#xE9;es et valid&#xE9;es par le CCIA. Il est pr&#xE9;vu la formation des acteurs sur ces directives en septembre 2021. Les directives de la vaccination au cours de la deuxi&#xE8;me ann&#xE9;e de vie sont en cours avec l?&#xE9;laboration des termes de r&#xE9;f&#xE9;rences</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support lab testing at 4 national and 5 regional labs that have been trained for the detection and characterization of bacterial meningitis and specimen referral;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Burkina Faso under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) strengthen nation-wide lab network through reinforcing proper specimen management and lab testing flows; 3) implement effective measures to improve laboratory quality, proficiency and data quality. 4) provide technical support for preparation and participation of annual meningitis meetings and other meetings">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Culture and PCR trainings were completed in September 2021 in Bobo-Dioulasso and Ouagadoudou for lab personnel from 7 national laboratories, including 5 existing and 2 new national laboratories (Ouaga-Yalgado, LNSP, Bogodogo, Charles De Gaulle, Centre Muraz, Sanou Souro, and Tengandogo). Culture capacity trainings were completed in August and September 2021 for biomedical technologists from 5 regional CHR/CMA laboratories. On-site training for 70 districts in bacteriology (Gram straining) were conducted, which was followed up with a proficiency testing at the 5 regional laboratories in September 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete second round of data cleaning</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assessment of impact and effectiveness of Rotasiil in Burkina Faso">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Culture capacity trainings were completed in August and September 2021 for biomedical technologists from 5 regional CHR/CMA laboratories.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluation of data management and specimen transport system efficiency and integration status</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Burkina Faso under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preparation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">STELab 2.0 is an African developed, integrated multi-disease data management and specimen tracking system with case-based reporting modules for Meningococcal Disease, Pneumococcal disease, Hib, Cholera, SARI, Dengue, measles, rubella, polio, Yellow Fever, and COVID-19. This new multi-disease version of STELab was rolled out in Burkina Faso in Q3 2020 and has been crucial to the country&apos;s COVID-19 testing program. A comprehensive evaluation of the STELab 2.0 system will be completed in Q3 2021 to assess impact of COVID-19 pandemic and the humanitarian crisis on completeness and timeliness of meningitis data management and specimen transport.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Generation of routine meningitis surveillance performance feedback summaries to guide national monitoring and evaluation, with a target of &gt;90% of participating districts reporting data monthly and &gt;80 of suspected meningitis cases have a specimen collected</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Burkina Faso under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preparation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">STELab 2.0 is an African developed, integrated multi-disease data management and specimen tracking system with case-based reporting modules for Meningococcal Disease, Pneumococcal disease, Hib, Cholera, SARI, Dengue, measles, rubella, polio, Yellow Fever, and COVID-19. This new multi-disease version of STELab was rolled out in Burkina Faso in Q3-Q4 2020 and has been crucial to the country&apos;s COVID-19 testing program. A comprehensive evaluation of the STELab 2.0 system is in process to assess impact of COVID-19 pandemic and the humanitarian crisis on completeness and timeliness of meningitis data management and specimen transport.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete first round of data cleaning</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assessment of impact and effectiveness of Rotasiil in Burkina Faso">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Surveillance is currently ongoing but has been slowed by COVID-19 response activities in the country. Data sharing is somewhat irregular which has delayed data cleaning and summary of the first year of results. Active discussions are ongoing to ensure data cleaning and analysis can occur on a regular basis.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assessment of impact and effectiveness of Rotasiil in Burkina Faso">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Surveillance is currently ongoing but has been slowed by COVID-19 response activities in the country. Remote technical assistance is ongoing to improve data quality and continued collection of data. Additional assessment of the data is needed to determine the full impact of COVID-19 on surveillance quality. A site visit to review surveillance activities, data quality, and implementation of vaccine switch will be scheduled when travel is once again permitted.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluate specimen management and lab testing flows for meningitis within national laboratory network; Develop a standardized program to ensure lab quality and proficiency</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Burkina Faso under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) strengthen nation-wide lab network through reinforcing proper specimen management and lab testing flows; 3) implement effective measures to improve laboratory quality, proficiency and data quality. 4) provide technical support for preparation and participation of annual meningitis meetings and other meetings">
      <location ref="BF"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">This proposed activity did not get funded under this grant. Reporting is not applicable.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le sites b&#xE9;n&#xE9;ficiaires des ECF solaires et ceux susceptibles de recevoir les ECF solaires sont visit&#xE9;s et les capacit&#xE9;s des gestionnaires du PEV sont renforc&#xE9;es.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apuyer le Minist&#xE8;re de la sant&#xE9; dans le suivi de l?installation et du fonctionnement des &#xE9;quipements de chaine de froid solaire">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;&#xE9;valuation des 617 sites ont &#xE9;t&#xE9; faites et 824 sites sont encours. Les ODP sont disponibles. 
Des sorties de suivi des &#xE9;quipements install&#xE9;s (310) ont &#xE9;t&#xE9; r&#xE9;alis&#xE9;s. 212 ECF sont en cours d&apos;installation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le sites b&#xE9;n&#xE9;ficiaires des ECF solaires et ceux susceptibles de recevoir les ECF solaires sont r&#xE9;guli&#xE8;rement visit&#xE9;s.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apuyer le Minist&#xE8;re de la sant&#xE9; dans le suivi de l?installation et du fonctionnement des &#xE9;quipements de chaine de froid solaire">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les sites identifees pour recevoir les ECF ont ete regulierement visitees.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le rapport g&#xE9;n&#xE9;ral de la SAV disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la semaine Africaine de la vaccination">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">L?OMS a apport&#xE9; son appui technique &#xE0; la mise en ?uvre de la semaine africaine de vaccination de 2020 &#xE0; travers l?appui &#xE0; l?&#xE9;laboration du plan de mise en ?uvre.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la semaine Africaine de la vaccination">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">L?OMS a apport&#xE9; son appui technique &#xE0; la mise en ?uvre de la semaine africaine de vaccination de 2020 &#xE0; travers l?appui &#xE0; l?&#xE9;laboration du plan de mise en ?uvre.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rapport d?activit&#xE9; du premier semestre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la surveillance sentinelle des diarrh&#xE9;es &#xE0; rotavirus">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">L?activit&#xE9; est en cours de r&#xE9;alisation dans les sites sentinelles de surveillance. Les sites sentinelles ont tenu les rencontres trimestrielles de bilan des activit&#xE9;s de la surveillance des diarrh&#xE9;es &#xE0; rotavirus, les rapports sont en cours d?&#xE9;laboration</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le rapport de l?introduction de la dose a la DN-HepB est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l?introduction de la DN-HepB (Dose &#xE0; la naissance du vaccin contre l?h&#xE9;patite B">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">L?introduction de la dose &#xE0; la naissance du vaccin contre l?h&#xE9;patite B (DN-HepB) n?est pas encore effectif. Le pays vient d?acqu&#xE9;rir les doses de vaccination. Les pr&#xE9;paratifs sont en cours pour d&#xE9;marrer l?introduction en d&#xE9;but d?ann&#xE9;e 2022. Cependant le plan d?introduction et le plan de communication ont &#xE9;t&#xE9; &#xE9;labor&#xE9;s. Les outils de collecte ont &#xE9;t&#xE9; &#xE9;galement r&#xE9;vis&#xE9;s pour prendre en compte la dose &#xE0; la naissance du vaccin contre l?h&#xE9;patite B.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le rapport d?activit&#xE9; de surveillance du rota virus disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la surveillance du rota virus">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les activit&#xE9;s de surveillance des diarrh&#xE9;es &#xE0; rotavirus des sites sentinelles se sont poursuivis au cours de ce semestre avec un total de 4532 d?&#xE9;chantillon collecte et analys&#xE9; au niveau des sites sentinelles. Tous les 4 sites sentinelles ont tenu leur r&#xE9;union trimestrielle d?&#xE9;change de planification, d?harmonisation et de validation des donn&#xE9;es de la surveillance. Les quatre sites on b&#xE9;n&#xE9;ficie de supervision du niveau centrale avec l?appui technique de l?OMS.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la surveillance du rota virus">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les activit&#xE9;s de surveillance des diarrh&#xE9;es &#xE0; rotavirus des sites sentinelles se sont poursuivis au cours de ce semestre avec un total de 4532 d?&#xE9;chantillon collecte et analys&#xE9; au niveau des sites sentinelles. Tous les 4 sites sentinelles ont tenu leur r&#xE9;union trimestrielle d?&#xE9;change de planification, d?harmonisation et de validation des donn&#xE9;es de la surveillance. Les quatre sites on b&#xE9;n&#xE9;ficie de supervision du niveau centrale avec l?appui technique de l?OMS.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le document du RSS4 du pays est elabor&#xE9; et approuv&#xE9; par Gavi</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;elaboration du RSS4 par le pays">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">L?&#xE9;laboration du Planification totale du portefeuille (FPP) qui remplacera le RSS n?a pas encore d&#xE9;but&#xE9;. Les &#xE9;changes sont en cours pour le d&#xE9;marrage effectif avant la fin de l?ann&#xE9;e.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rapport de la revue disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la revue semestrielle du programme">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">La revue semestrielle du programme au compte du deuxi&#xE8;me semestre s?est tenue sous forme d?atelier organis&#xE9; en deux sessions de deux groupes. La premi&#xE8;re session s?est tenue du 26 au 30 Octobre 2021 et la deuxi&#xE8;me session du 02-05 Novembre 2021. Ces rencontres ont regroup&#xE9; les 13 directeurs r&#xE9;gionaux de la sant&#xE9;, les 70 m&#xE9;decins chef districts et leurs responsable PEV ainsi que les partenaire technique et financier intervenant dans la vaccination. Ces rencontres d&#xE9;centralis&#xE9;es ont permis de faire : 
?	Un bilan de la situation de la vaccination de routine et de la surveillance des maladies &#xE9;vitables par la vaccination ;
?	De faire une mise &#xE0; jour des connaissances des diff&#xE9;rents acteurs sur la vaccination et la surveillance des MEV ;
?	De partage de bonnes pratiques de gouvernance/gestion en surveillances et vaccination entre les diff&#xE9;rents acteurs ;
?	D?identifier les diff&#xE9;rents goulots/difficult&#xE9;s qui entravent la mise en ?uvre des activit&#xE9;s de vaccination et de la surveillance des maladies &#xE9;vitables par la vaccination ;
?	De d&#xE9;velopper des strat&#xE9;gies pour assurer une bonne int&#xE9;gration des diff&#xE9;rentes interventions de surveillance et de vaccination ;
?	D?&#xE9;changer sur les modalit&#xE9;s de gestion des vaccins (routine et COVID-19) et de la chaine du froid dans le contexte de COVID-19.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rapport d?&#xE9;laboration disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l?&#xE9;laboration de la strat&#xE9;gie nationale de vaccination 2021-2025">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Le Burkina Faso, &#xE0; l?instar des autres pays africains, s?inscrit dans la vision du programme de vaccination &#xE0; l?horizon 2030 qui vise &#xE0; permettre de pr&#xE9;server les acquis durement obtenus, mais &#xE9;galement &#xE0; &#xE9;tendre les r&#xE9;alisations, afin de ne laisser personne de c&#xF4;t&#xE9;, quelle que soit la situation ou l?&#xE9;tape de la vie. A cet effet le Minist&#xE8;re de la sant&#xE9; a entrepris l?&#xE9;laboration de sa Strat&#xE9;gie nationale de vaccination 2021-2025 depuis juillet 2021avec l?Appui technique et financier de l?OMS &#xE0; travers les fonds TCA/Gavi. Ainsi plusieurs ateliers ont &#xE9;t&#xE9; conduits, ce qui a permis d?aboutir &#xE0; un draft prenant en compte les axes strat&#xE9;gie d&#xE9;fini dans le programme IA2030 et prenant en compte la strat&#xE9;gie 5.0 de Gavi en vue de r&#xE9;duire le nombre d?enfant z&#xE9;ro dose. Dans le cadre de l?&#xE9;laboration les activit&#xE9;s suivantes ont &#xE9;t&#xE9; r&#xE9;alis&#xE9;es :
?	Organisation de l?atelier pr&#xE9;paratoire avec l?ensemble des parties prenantes 
?	Elaboration de l?arr&#xEA;t&#xE9; de mise en place du comit&#xE9; national de l?&#xE9;laboration de la NIS 
?	Tenue de l?atelier sur l?analyse de la situation et l?identification des probl&#xE8;mes en travaux de groupe
?	Tenue de l?atelier d?identification des probl&#xE8;mes prioritaires, des strat&#xE9;gies et des activit&#xE9;s prioritaires
?	Tenue de l?atelier de consolidation des productions des groupes th&#xE9;matiques ayant permis de d&#xE9;terminer la chaine de r&#xE9;sultat et le cadre logique ;
?	R&#xE9;daction d?un draft du document de la NIS ;
?	Pr&#xE9;sentation du point d?&#xE9;tape de l?&#xE9;laboration de la NIS au CTA/PEV ;
?	Prise en compte des observations du CTA/PEV ;
?	Partage du draft avec l?&#xE9;quipe de l?IST ; 
?	Tenue d?un atelier d?int&#xE9;gration des amendements de l?&#xE9;quipe de l?IST et de consolidation du draft ; 
?	Pr&#xE9;sentation du point d?&#xE9;tape de l?&#xE9;laboration de la SNV au CCIA ;
?	Tenue d?un atelier d?identification et de planification des activit&#xE9;s de la SNV en vue du costing.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">TDR et outils &#xE9;labor&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l?&#xE9;laboration de la strat&#xE9;gie nationale de vaccination 2021-2025">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les termes de r&#xE9;f&#xE9;rence ainsi que les outils pour l?&#xE9;laboration de la strat&#xE9;gie nationale de vaccination ont &#xE9;t&#xE9; produite et utiliser pour l?&#xE9;laboration du document. Le pays dispose actuellement un draft de la strat&#xE9;gie nationale de vaccination 2021-2025</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l?&#xE9;laboration de la strat&#xE9;gie nationale de vaccination 2021-2025">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">activit&#xE9; non encore r&#xE9;alis&#xE9;e car le guide de r&#xE9;f&#xE9;rence pour l?&#xE9;laboration de la strat&#xE9;gie nationale de vaccination dans le cadre de l?Agenda de la vaccination 2030 ne sont pas encore disponibles.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">L&apos;atelier de r&#xE9;vision des outils de gestion des vaccins est r&#xE9;alis&#xE9;.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la r&#xE9;vision et la reproduction des outils de gestion des vaccins">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Complete en Novembere 2020</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les outils de gestions revis&#xE9;s sont disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la r&#xE9;vision et la reproduction des outils de gestion des vaccins">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les outils de gestion ont &#xE9;t&#xE9; r&#xE9;vis&#xE9;s et reproduits.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Toutes les recommandations issues de l&apos;analyse de l&apos;&#xE9;quit&#xE9; sont mises en ?uvre.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre des recommandations issues de l?analyse de l?&#xE9;quit&#xE9; en immunisation et le suivi des micro-plans pro-&#xE9;quit&#xE9;s.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les recommandations majeures de l&apos;analyse de l&apos;&#xE9;quit&#xE9; en immunisation ont &#xE9;t&#xE9; mises en ?uvre (75%):
-Tous les districts sanitaires (DS) et les centres de sant&#xE9; de promotion sociale (CSPS) ont finalis&#xE9; leurs micro-plans pro-&#xE9;quit&#xE9;s. Les DS et CSPS sont maintenant outill&#xE9;s pour une mise en ?uvre des interventions int&#xE9;grant l&apos;&#xE9;quit&#xE9; en vaccination.
-228 CSPS ont b&#xE9;n&#xE9;fici&#xE9; des motos achet&#xE9;es par l&apos;UNICEF sur financement de GAVI/RSS3 (Convention de subvention N&#xB0; 2019-001/MS/SG/PADS/GAVI-RSS). Aussi, 235 motos ont &#xE9;t&#xE9; acquis par le PRSS au profit des CSPS. Ces CSPS pourront maintenant r&#xE9;aliser des strat&#xE9;gies avanc&#xE9;es afin de vacciner les enfants vivants dans les zones &#xE9;loign&#xE9;es et d?acc&#xE8;s difficiles. Deux consultants nationaux ont ete recrut&#xE9;s pour appuyer le Minist&#xE8;re. L&apos;&#xE9;valution de la mise en oeuvre des plan est en cours par les deux consutants et trois r&#xE9;gions et huit (08) ont &#xE9;t&#xE9; &#xE9;valu&#xE9;s.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre des recommandations issues de l?analyse de l?&#xE9;quit&#xE9; en immunisation et le suivi des micro-plans pro-&#xE9;quit&#xE9;s.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les recommandations majeures de l&apos;analyse de l&apos;&#xE9;quit&#xE9; en immunisation ont &#xE9;t&#xE9; mises en ?uvre (75%):
-Tous les districts sanitaires (DS) et les centres de sant&#xE9; de promotion sociale (CSPS) ont finalis&#xE9; leurs micro-plans pro-&#xE9;quit&#xE9;s. Les DS et CSPS sont maintenant outill&#xE9;s pour une mise en ?uvre des interventions int&#xE9;grant l&apos;&#xE9;quit&#xE9; en vaccination.
-228 CSPS ont b&#xE9;n&#xE9;fici&#xE9; des motos achet&#xE9;es par l&apos;UNICEF sur financement de GAVI/RSS3 (Convention de subvention N&#xB0; 2019-001/MS/SG/PADS/GAVI-RSS). Aussi, 235 motos ont &#xE9;t&#xE9; acquis par le PRSS au profit des CSPS. Ces CSPS pourront maintenant r&#xE9;aliser des strat&#xE9;gies avanc&#xE9;es afin de vacciner les enfants vivants dans les zones &#xE9;loign&#xE9;es et d?acc&#xE8;s difficiles. Deux consultants nationaux ont ete recrut&#xE9;s pour appuyer le Minist&#xE8;re. L&apos;&#xE9;valution de la mise en oeuvre des plan est en cours par les deux consutants et trois r&#xE9;gions et huit (08) ont &#xE9;t&#xE9; &#xE9;valu&#xE9;s.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Human Resources for Health</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">TDR et outils de supervision &#xE9;labor&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la supervision formative des districts &#xE0; faible performance assorti de plan de r&#xE9;solution des probl&#xE8;mes">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les termes de r&#xE9;f&#xE9;rence et la grillade supervision des districts &#xE0; faible performance ont &#xE9;t&#xE9; &#xE9;labor&#xE9;. 8 districts sanitaires &#xE0; faible performance ont &#xE9;t&#xE9; cibl&#xE9;s dans ce cadre pour recevoir de l?appui.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les termes de r&#xE9;f&#xE9;rence et les outils de la formation sont &#xE9;labor&#xE9;s et valid&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les comp&#xE9;tences des cadres de la DPV sur les modules compl&#xE9;mentaires MLM (Midle Level Management) et &#xE0; l?adaptation des modules et au renforcement des comp&#xE9;tences des &#xE9;quipes cadre des districts sur les modules (l?approche de r&#xE9;solution des probl&#xE8;mes, la planification des activit&#xE9;s de vaccination, la supervision formative))">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les termes de r&#xE9;f&#xE9;rence pour le renforcer les comp&#xE9;tences des cadres de la DPV sur les modules compl&#xE9;mentaires sur le management du programme de vaccination ont &#xE9;t&#xE9; &#xE9;labor&#xE9; et valid&#xE9;. La formation est programm&#xE9;e en f&#xE9;vrier 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les comp&#xE9;tences des cadres de la DPV sur les modules compl&#xE9;mentaires MLM (Midle Level Management) et &#xE0; l?adaptation des modules et au renforcement des comp&#xE9;tences des &#xE9;quipes cadre des districts sur les modules (l?approche de r&#xE9;solution des probl&#xE8;mes, la planification des activit&#xE9;s de vaccination, la supervision formative))">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">l?activit&#xE9; n?as pas encore d&#xE9;marr&#xE9; car les acteurs sont enr&#xF4;l&#xE9;s pour la campagne de de vaccination contre la covid-19</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rapport d?&#xE9;laboration disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l?&#xE9;laboration du PAQD 2021-2025">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">L?activit&#xE9; non encore r&#xE9;alis&#xE9; &#xE0; cause de la mobilisation des acteurs pour l?acc&#xE9;l&#xE9;ration de la vaccination contre la COVID-19. L?activit&#xE9; a &#xE9;t&#xE9; reprogramm&#xE9; en janvier 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">TDR et outils de formation &#xE9;labor&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les capacit&#xE9;s des responsables PEV sur l?analyse des donn&#xE9;es de vaccination dans le DHIS2">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les termes de r&#xE9;f&#xE9;rence pour le renforcement les comp&#xE9;tences des responsables en charge de vaccination sur l?analyse et l?am&#xE9;lioration de la qualit&#xE9; des donn&#xE9;es de vaccination ont &#xE9;t&#xE9; &#xE9;labor&#xE9;s. Cependant l?adaptation des outils de formation sont en cours.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les DS moins performants sont repertori&#xE9;s, les strat&#xE9;gies d&apos;appui sont fix&#xE9;es et le d&#xE9;marrage de l&apos;assistance &#xE0; la DPV est effectif.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DPV dans le suivi des activit&#xE9;s du PEV routine et la mise en ?uvre des plans d&apos;actions correctives issues de l&apos;analyse de l&apos;&#xE9;quit&#xE9; en immunisation en particulier dans zones &#xE0; securit&#xE9; precaire et dans les zones urbaine et peri urbaines">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">13 districts ont &#xE9;t&#xE9; appuy&#xE9;s pour la mise oeuvre des strat&#xE9;gies sp&#xE9;cifiques ((Strat&#xE9;gie des march&#xE9;s, des zones non loties, site d?orpaillage artisanal, zones &#xE0; securit&#xE9; pr&#xE9;caire) en vue d?atteindre les enfants z&#xE9;ro dose et les enfants non &#xE0; jour du calendrier vaccinal: Formation des acteurs des districicts et des sites de vaccination sur la vaccination contre la COVID-19. 
L&apos;analyse des donn&#xE9;es de couverture vaccinale est faite mensuellement et les districts les moins performants sont repertori&#xE9;s; ils sont appuy&#xE9;s financi&#xE8;rement pour la mise en ?uvre d&apos;intensification de la vaccination.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Deux ateliers de conception et de validation de la strat&#xE9;gie et du plan d&apos;action de l&apos;engagement communautaire en faveur de la vaccination dans les quartiers pr&#xE9;caires et zones &#xE0; d&#xE9;fis s&#xE9;curitaires sont r&#xE9;alis&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre d&apos;un m&#xE9;canisme d&apos;engagement communautaire (dialogues communautaires, messages des leaders, etc.), y compris l?engagement des leaders (religieux, traditionnels et coutumiers et associatifs), des relais communautaires et des champions pour la promotion de la vaccination dans le contexte de Covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVc2 en mettant un accent dans les quartiers pr&#xE9;caires et zones &#xE0; d&#xE9;fis s&#xE9;curitaires.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">* M&#xE9;canismes d&apos;engagement communautaire &#xE0; travers l&apos;organisation des dialogues communautaires mise en place dans la r&#xE9;gion du Nord &#xE0; travers la radio &quot;Voix du paysan&quot;.
 * M&#xE9;canismes en cours de mise en oeuvre dans la r&#xE9;gion de l&apos;Est avec l&apos;Association TinTaani
 * Formation des relais mobilisateurs et des U-reporters sur la conduite du dialogue communautaire
 * Mise en ?uvre de la communication de proximit&#xE9; au profit des districts dans les r&#xE9;gions du centre est, boucle du mouhoun sud-oeust
 * Diffusion des messages d&apos;appel des leaders coutumiers et religieux 
 * Installation des champions nationaux de la vaccination (13 champions)</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre d&apos;un m&#xE9;canisme d&apos;engagement communautaire (dialogues communautaires, messages des leaders, etc.), y compris l?engagement des leaders (religieux, traditionnels et coutumiers et associatifs), des relais communautaires et des champions pour la promotion de la vaccination dans le contexte de Covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVc2 en mettant un accent dans les quartiers pr&#xE9;caires et zones &#xE0; d&#xE9;fis s&#xE9;curitaires.">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Activite non encore realisee.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le Rapport d&apos;activit&#xE9; est disponible.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les capacit&#xE9;s des animateurs des radios et des Relais Communautaires sur les approches et techniques de sensibilisation de proximit&#xE9;.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Cette activit&#xE9; a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e dans le cadre de la mise en oeuvre des plans int&#xE9;gr&#xE9;s de communication (PIC) vaccination dans les r&#xE9;gions du Centre-est, centre-sud, Est, sahel et centre nord.
Des journalistes et relais communautaires ont &#xE9;t&#xE9; form&#xE9;s dans le Centre-sud et et le Centre-est.
Il y a eu &#xE9;galement la production de la bo&#xEE;te &#xE0; image sur le calendrier vaccinal.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les capacit&#xE9;s des animateurs des radios et des Relais Communautaires sur les approches et techniques de sensibilisation de proximit&#xE9;.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Cette activit&#xE9; a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e dans le cadre de la mise en oeuvre des plans int&#xE9;gr&#xE9;s de communication (PIC) vaccination dans les r&#xE9;gions du Centre-est, centre-sud, Est, sahel et centre nord.
Des journalistes et relais communautaires ont &#xE9;t&#xE9; form&#xE9;s dans le Centre-sud et et le Centre-est.
Il y a eu &#xE9;galement la production de la bo&#xEE;te &#xE0; image sur le calendrier vaccinal.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le Consultant international est recrut&#xE9; et un atelier de concertation pour l&apos;&#xE9;laboration du plan d&apos;action est organis&#xE9;.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre des strat&#xE9;gies sp&#xE9;cifiques (Strat&#xE9;gie des march&#xE9;s, des zones non loties, urbaine p&#xE9;ri urbaine, site d?orpaillage artisanal, zones &#xE0; securit&#xE9; pr&#xE9;caire) en vue d?atteindre les enfants z&#xE9;ro dose et les enfants non &#xE0; jour du calendrier vaccinal">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Le consultant est recrut&#xE9; et est en place..Des draft sdes plans des regions cibl&#xE9;s du Centre et des Hauts Bassins sont disponibles et seront finalis&#xE9;s.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les TDR pour le recrutement du Consultant international sont &#xE9;labor&#xE9;s.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre des strat&#xE9;gies sp&#xE9;cifiques (Strat&#xE9;gie des march&#xE9;s, des zones non loties, urbaine p&#xE9;ri urbaine, site d?orpaillage artisanal, zones &#xE0; securit&#xE9; pr&#xE9;caire) en vue d?atteindre les enfants z&#xE9;ro dose et les enfants non &#xE0; jour du calendrier vaccinal">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Le draft de TDR pour le recrutement du consultant sont disponible.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le plan d&apos;action de l&apos;engagement communautaire en faveur de la vaccination dans les quartiers pr&#xE9;caires et zones &#xE0; d&#xE9;fis s&#xE9;curitaires est mise en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre d&apos;un m&#xE9;canisme d&apos;engagement communautaire (dialogues communautaires, messages des leaders, etc.), y compris l?engagement des leaders (religieux, traditionnels et coutumiers et associatifs), des relais communautaires et des champions pour la promotion de la vaccination dans le contexte de Covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVc2 en mettant un accent dans les quartiers pr&#xE9;caires et zones &#xE0; d&#xE9;fis s&#xE9;curitaires.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Le plan d&apos;actyion est finalis&#xE9; et sa mise en oeuvre est en cours.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le plan de communication sur les risques et la strat&#xE9;gie de gestion des rumeurs li&#xE9;es &#xE0; la vaccination sont mis en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la communication sur les risques et la promotion des bonnes pratiques de vaccination dans le contexte de Covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVc2 en mettant un accent particulier sur la vaccination au cours de la 2eme ann&#xE9;e de vie.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Le plan de communication sur les risques est developp&#xE9; et est en cours de mise en oeuvre .</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La strat&#xE9;gie enfant pour enfant pour la promotion de la vaccination dans le contexte de covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVC2 est &#xE9;labor&#xE9;e et valid&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre de la strat&#xE9;gie enfant pour enfant pour la promotion de la vaccination dans le contexte de covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVC2, &#xE0; travers les &#xE9;coles, les espaces et plateformes des enfants et adolescents">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">La strat&#xE9;gie a &#xE9;t&#xE9; r&#xE9;dig&#xE9;e et le document disponible. En termes de prochaines &#xE9;tapes, il est pr&#xE9;vu sa validation, son pretest avant sa mise &#xE0; l&apos;echelle.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre de la strat&#xE9;gie enfant pour enfant pour la promotion de la vaccination dans le contexte de covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVC2, &#xE0; travers les &#xE9;coles, les espaces et plateformes des enfants et adolescents">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Non encore realise. Financement non recu</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les modules de formations sur l?engagement communautaire et la communication sur les risques sont &#xE9;labor&#xE9;s et valid&#xE9;s.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la formation des Responsables de Promotion de Sant&#xE9; (RPS) des Directions R&#xE9;gionales de la Sant&#xE9; et des Districts Sanitaires sur les approches de l?engagement communautaire et de la communication sur les risques pour assurer la continuit&#xE9; et la qualit&#xE9; des services de vaccination dans le contexte de covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVC2">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Modules are developped. Community engagement mechanisms have been put in place through the organization of community dialogues in the North region and the North Center region through national NGOs, namely the radio ?Voix du paysan? and ?Action Communautaire pour Development &quot;
Other activities carried out:
-	Training of community relays and U-reporters on the conduct of community dialogues.
-	Implementation of local communication for the benefit of the districts in the Center-East, Boucle du Mouhoun and South-West regions.
-	Dissemination of messages of appeal from customary and religious leaders
-	Installation of national immunization champions (13 champions)</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la formation des Responsables de Promotion de Sant&#xE9; (RPS) des Directions R&#xE9;gionales de la Sant&#xE9; et des Districts Sanitaires sur les approches de l?engagement communautaire et de la communication sur les risques pour assurer la continuit&#xE9; et la qualit&#xE9; des services de vaccination dans le contexte de covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVC2">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Non encore realisee. Financement non encore disponible</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le plan de communication sur les risques et la strat&#xE9;gie de gestion des rumeurs li&#xE9;es &#xE0; la vaccination sont &#xE9;labor&#xE9;s.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la communication sur les risques et la promotion des bonnes pratiques de vaccination dans le contexte de Covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVc2 en mettant un accent particulier sur la vaccination au cours de la 2eme ann&#xE9;e de vie.">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Non realisee. Financement non disponible</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la communication sur les risques et la promotion des bonnes pratiques de vaccination dans le contexte de Covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVc2 en mettant un accent particulier sur la vaccination au cours de la 2eme ann&#xE9;e de vie.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Unicef supported the development of the plan on risk management. UNICEF supported the establishment and animation of a working group comprising of the Ministry of Health, UNICEF, WHO, the Red Cross, NGOs and influencers for the management of rumors related to the vaccine. COVID-19. Rumors and disinformation are followed up and responses are continually being made via social networks (Facebook, Twitter and ...) and U-reporters.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les outils de la strat&#xE9;gie enfant pour enfant pour la promotion de la vaccination dans le contexte de covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVC2 sont d&#xE9;velopp&#xE9;s et la strat&#xE9;gie est mise en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre de la strat&#xE9;gie enfant pour enfant pour la promotion de la vaccination dans le contexte de covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVC2, &#xE0; travers les &#xE9;coles, les espaces et plateformes des enfants et adolescents">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Non r&#xE9;alis&#xE9;e report&#xE9;e en 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un staff international Immunization specialist (niveau P3) est recrut&#xE9; pour appuyer les activit&#xE9;s PEV.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DPV dans le suivi des activit&#xE9;s du PEV routine et la mise en ?uvre des plans d&apos;actions correctives issues de l&apos;analyse de l&apos;&#xE9;quit&#xE9; en immunisation en particulier dans zones &#xE0; securit&#xE9; precaire et dans les zones urbaine et peri urbaines">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Staff internetional recrute et a termine sa periode de contrat.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les RPS des DRS et DS sont form&#xE9;s sur les approches de l?engagement communautaire et de la communication sur les risques pour assurer la continuit&#xE9; et la qualit&#xE9; des services de vaccination dans le contexte de covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVC2</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la formation des Responsables de Promotion de Sant&#xE9; (RPS) des Directions R&#xE9;gionales de la Sant&#xE9; et des Districts Sanitaires sur les approches de l?engagement communautaire et de la communication sur les risques pour assurer la continuit&#xE9; et la qualit&#xE9; des services de vaccination dans le contexte de covid-19 et de l?&#xE9;pid&#xE9;mie du PVDVC2">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Un brienfing en cascade est organis&#xE9; en faveur des RPS et SPS en pr&#xE9;lude &#xE0; chaque round. L&apos;ensemble des 13 SPS et 70 RPS ont b&#xE9;n&#xE9;fici&#xE9; d&apos;une formation en RCCE</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les formations des enfants, adolecents, jeunes et enseignants sont r&#xE9;alis&#xE9;es et les rapports des formations sont disponibles.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les connaissances et les comp&#xE9;tences des enfants, des adolescents et des jeunes sur la promotion de la vaccination et conduire l&apos;&#xE9;valuation de l&apos;activit&#xE9; r&#xE9;alis&#xE9;e.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Une strategie assortie d&apos;outil d&apos;engagement des enfants et adolescente a ete elabore. Sa mise en oeuvre a ete mise dans le Centre Est et le Centre Sud a travers les activites dans les ecoles y compris le briefing des enseignants sur la vaccination.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">L&apos;&#xE9;valuation est r&#xE9;alis&#xE9;e et le rapport est disponible.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les connaissances et les comp&#xE9;tences des enfants, des adolescents et des jeunes sur la promotion de la vaccination et conduire l&apos;&#xE9;valuation de l&apos;activit&#xE9; r&#xE9;alis&#xE9;e.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Une strat&#xE9;gie assortie d&apos;outils d&apos;engagement des enfants et adolescents a &#xE9;t&#xE9; &#xE9;labor&#xE9;e. Sa mise en oeuvre a commenc&#xE9; dans le Centre-est et le centre-sud &#xE0; travers les activit&#xE9;s dans les &#xE9;coles y compris le briefing des enseignants sur la vaccination de routine.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer les connaissances et les comp&#xE9;tences des enfants, des adolescents et des jeunes sur la promotion de la vaccination et conduire l&apos;&#xE9;valuation de l&apos;activit&#xE9; r&#xE9;alis&#xE9;e.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Une strat&#xE9;gie assortie d&apos;outils d&apos;engagement des enfants et adolescents a &#xE9;t&#xE9; &#xE9;labor&#xE9;e. Sa mise en oeuvre a commenc&#xE9; dans le Centre-est et le centre-sud &#xE0; travers les activit&#xE9;s dans les &#xE9;coles y compris le briefing des enseignants sur la vaccination de routine.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">PATH : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV vaccine introduced</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the introduction of HPV vaccine">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">HPV introduction was initially planned for November 2021. The whole porcess has experienced significant delays, including delay in communication and social mobiisation. Therefore, it is very likely that the launch will be postponed and that a new date will be proposed, possibly for early 2022 launch.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Supportive supervision conducted after introduction and launch</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support supportive supervision during implementation of dose 1 and dose 2 of HPV vaccines">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Not applicable. This will come following the launch targeted for early 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Participated in monitoring of routine HPV vaccination surveillance data after introduction</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the surveillance of routine HPV vaccination data n">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Not applicable. This will come following the launch targeted for early 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training modules and training plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the development of training modules and training plan">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">PATH has supported the development of training modules for HPV in 2 consectuve one-week workshops. The first workshop gathered a small number of persons who drafted the material. The second workshop gathered a larger audience to review and validate the materias developped.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Communication materials and social mobilization plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the development of communication tools and plan for social mobilization">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">PATH supported the development of communication and social mobilization material. These include posters, banners and a technical guidance on how to communicate on HPV at different levels of the Health system.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Work plan and chronogram of activities developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the development of a chronogram and work plan for HPV vaccine introduction">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">These have been developped with PATH support. But given the delay in the implementation ofthe activities of the chronogram, the chronogram is subject to ongoing revisions.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Preliminary summary of first year of data</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assessment of impact and effectiveness of Rotasiil in Burkina Faso">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Surveillance is currently ongoing but has been slowed by COVID-19 response activities in the country. Data sharing is somewhat irregular which has delayed data cleaning and summary of the first year of results. Active discussions are ongoing to ensure data cleaning and analysis can occur on a regular basis.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assessment of impact and effectiveness of Rotasiil in Burkina Faso">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Surveillance is currently ongoing but has been slowed by COVID-19 response activities in the country. Remote technical assistance is ongoing to improve data quality and continued collection of data. A preliminary summary of the first year of data will be produced over the summer of 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assessment of impact and effectiveness of Rotasiil in Burkina Faso">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Surveillance is currently ongoing but has been slowed by COVID-19 response activities in the country. Remote technical assistance is ongoing to improve data quality and continued collection of data. A preliminary summary of the first year of data will be produced over the summer of 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Completion of first round of data cleaning</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assessment of impact and effectiveness of Rotasiil in Burkina Faso">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Surveillance is currently ongoing but has been slowed by COVID-19 response activities in the country. Remote technical assistance is ongoing to improve data quality and continued collection of data. Additional assessment of the data is needed to determine the full impact of COVID-19 on surveillance quality. A site visit to review surveillance activities, data quality, and implementation of vaccine switch will be scheduled when travel is once again permitted.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete trainings on data management and analysis processes;Complete supervision visits to at least 5 sites; Complete analysis &gt;90% of specimens collected in 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Burkina Faso under OneTA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens; 2) reinforce quality control programs to ensure laboratory proficiency within the nation wide laboratory system; 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Despite COVID-19, an ongoing humanitarian crisis and security issues in districts on the border with Niger and Mali, CDC through leadership of MenAfriNet, strengthened case-based surveillance in Burkina Faso as a strategic country at high risk for meningitis disease and epidemics. Thus far in 2021, surveillance system health was monitored, and technical assistance provided remotely through five monthly MenAfriNet Surveillance and Data Management Working Group teleconferences. Burkina Faso continues to be the only country to maintain high quality national meningitis case-based surveillance?through June 2021, 100% (70/70) districts were sharing case-based data monthly and &gt;95% of suspected meningitis cases have a specimen collected and sent for lab confirmation (see MenAfriNet Surveillance Feedback Bulletin; www.menafrinet.com). STELab 2.0 multi-disease data management and specimen tracking system is fully operational nationally with case-based reporting modules for Meningococcal Disease, Pneumococcal disease, Hib, Cholera, SARI, Dengue, measles, rubella, polio, Yellow Fever, and COVID-19. 2019 and 2020 validated data will be analyzed and Summary MenAfriNet Surveillance Reports to be published next quarter. By Q4 2021, validated data will archived in the public domain and used to update models to inform multivalent meningococcal vaccine implementation strategies; particularly subnational trends in non-A meningococcal disease due to non-A serogroups (i.e. C, W, X, Y). Next quarter, a regional analytic training, using the R package, will be held in Burkina Faso.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Burkina Faso under OneTA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens; 2) reinforce quality control programs to ensure laboratory proficiency within the nation wide laboratory system; 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Despite COVID-19, an ongoing humanitarian crisis and security issues in districts on the border with Niger and Mali, CDC through leadership of MenAfriNet, strengthened case-based surveillance in Burkina Faso as a strategic country at high risk for meningitis disease and epidemics. Thus far in 2021, surveillance system health was monitored, and technical assistance provided remotely through five monthly MenAfriNet Surveillance and Data Management Working Group teleconferences. Burkina Faso continues to be the only country to maintain high quality national meningitis case-based surveillance?through June 2021, 100% (70/70) districts were sharing case-based data monthly and &gt;95% of suspected meningitis cases have a specimen collected and sent for lab confirmation (see MenAfriNet Surveillance Feedback Bulletin; www.menafrinet.com). STELab 2.0 multi-disease data management and specimen tracking system is fully operational nationally with case-based reporting modules for Meningococcal Disease, Pneumococcal disease, Hib, Cholera, SARI, Dengue, measles, rubella, polio, Yellow Fever, and COVID-19. 2019 and 2020 validated data will be analyzed and Summary MenAfriNet Surveillance Reports to be published next quarter. By Q4 2021, validated data will archived in the public domain and used to update models to inform multivalent meningococcal vaccine implementation strategies; particularly subnational trends in non-A meningococcal disease due to non-A serogroups (i.e. C, W, X, Y). Next quarter, a regional analytic training, using the R package, will be held in Burkina Faso.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Consistent weekly reporting of meningitis cases and testing of CSF obtained from participating districts; generation of weekly meningitis surveillance bulletins/reports for MOH and key partners to monitor trends in meningitis disease and early detection of epidemics.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Burkina Faso under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring, early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile)">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020, and supervisory trainings on meningitis diagnosis and specimen transport were completed in December 2020. A total of 40 laboratory scientists were trained in Bobo-Dioulasso and Ouagadougou to improve laboratory confirmation for case based meningitis surveillance. Supervisory training topics include general facts about bacterial pathogens, specimen management, cytology, lab quality and safety and lab network in Burkina Faso. Burkina Faso is on the right track completing the testing and analysis of all specimens.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Burkina Faso under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring, early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile)">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020, and supervisory trainings on meningitis diagnosis and specimen transport were completed in December 2020. A total of 40 laboratory scientists were trained in Bobo-Dioulasso and Ouagadougou to improve laboratory confirmation for case based meningitis surveillance. Supervisory training topics include general facts about bacterial pathogens, specimen management, cytology, lab quality and safety and lab network in Burkina Faso. Burkina Faso is on the right track completing the testing and analysis of all specimens.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete training of 4 national and &gt;4 regional labs on detection of bacterial meningitis using the latest effective technology; Implement in-country programs to ensure lab proficiency. Complete analysis &gt;90% of specimens collected between Jan-Aug 2020;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Burkina Faso under OneTA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens; 2) reinforce quality control programs to ensure laboratory proficiency within the nation wide laboratory system; 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on meningitis diagnosis were completed in December 2020 (7-10 Dec 2020). A total of 40 laboratory scientists from 2 regions (Bobo and Ouaga) were trained to improve laboratory confirmation for diagnosis of bacterial meningitis (cytology, latex agglutination, TI inoculation). The supervisory visits combined with quality programs in 12 districts focusing on documentation, data management, PT were completed in December 2020 (14-24 Dec). All specimens received at national level were tested by PCR.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">World Bank : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Delivery of the training modules and the programmatic budget advances with Finance.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TCA 2019 was the first year of engagement of the GAVI-WBG partnership in Burkina Faso. Following the January 2019 joint mission conclusions, the team is preparing elements for a public expenditure review, with an initial focus on the budget cycle and gratuit&#xE9;. These were to be delivered for the December UHC Financing Forum, which is likely to be moved to the first quarter of 2020. Additional notes are planned, including one to support prospective evaluation of budget allocation, and will be discussed with donors and the ministry. The results will feed into the forum discussion on efficiency of public spending and will support better budgeting in 2020 by the ministry and its partners through a revision of the budgeting approach to focus on priority results. The 2020 TCA will involve two parts that will be mutually-reinforcing. Centrally, the team will support the Ministry of Health with the Ministry of Finance on programmatic budgeting including questions of budgetary flexibility and implementation of prospective budget reviews to support the ministry in dealing with budget cuts and to better align the budget to the MoH objectives. This will complement planned work by CHAI and a USAID contractor. The team will also work with the Ministries of Health and Finance to develop new modules on programmatic and priority-based budgeting for the annual training of district medical officers. This training is supported by the WB-financed PRSS operation and all future ministry management staff go through this training program. Therefore, the training will has the potential to have downstream impacts beyond the initial training. There is the potential to also provide support to the Ministry of Health to better allocate human resources with the newly-developed human resource database and the Workload Indicative Staffing Needs information. This is closely linked to the ongoing Development Policy Financing?s measure to strengthen human resources in rural areas. The team has identified as an additional possible reform measure that requires technical assistance to develop tools to help ministry staff to better understand their human and material resources to adjust allocations.">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Work in progress with minor delays due to COVID-19.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TCA 2019 was the first year of engagement of the GAVI-WBG partnership in Burkina Faso. Following the January 2019 joint mission conclusions, the team is preparing elements for a public expenditure review, with an initial focus on the budget cycle and gratuit&#xE9;. These were to be delivered for the December UHC Financing Forum, which is likely to be moved to the first quarter of 2020. Additional notes are planned, including one to support prospective evaluation of budget allocation, and will be discussed with donors and the ministry. The results will feed into the forum discussion on efficiency of public spending and will support better budgeting in 2020 by the ministry and its partners through a revision of the budgeting approach to focus on priority results.



The 2020 TCA will involve two parts that will be mutually-reinforcing. Centrally, the team will support the Ministry of Health with the Ministry of Finance on programmatic budgeting including questions of budgetary flexibility and implementation of prospective budget reviews to support the ministry in dealing with budget cuts and to better align the budget to the MoH objectives. This will complement planned work by CHAI and a USAID contractor. The team will also work with the Ministries of Health and Finance to develop new modules on programmatic and priority-based budgeting for the annual training of district medical officers. This training is supported by the WB-financed PRSS operation and all future ministry management staff go through this training program. Therefore, the training will has the potential to have downstream impacts beyond the initial training.



There is the potential to also provide support to the Ministry of Health to better allocate human resources with the newly-developed human resource database and the Workload Indicative Staffing Needs information. This is closely linked to the ongoing Development Policy Financing?s measure to strengthen human resources in rural areas. The team has identified as an additional possible reform measure that requires technical assistance to develop tools to help ministry staff to better understand their human and material resources to adjust allocations.">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Work program is progressing with delays to due to COVID-19.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TCA 2019 was the first year of engagement of the GAVI-WBG partnership in Burkina Faso. Following the January 2019 joint mission conclusions, the team is preparing elements for a public expenditure review, with an initial focus on the budget cycle and gratuit&#xE9;. These were to be delivered for the December UHC Financing Forum, which is likely to be moved to the first quarter of 2020. Additional notes are planned, including one to support prospective evaluation of budget allocation, and will be discussed with donors and the ministry. The results will feed into the forum discussion on efficiency of public spending and will support better budgeting in 2020 by the ministry and its partners through a revision of the budgeting approach to focus on priority results.



The 2020 TCA will involve two parts that will be mutually-reinforcing. Centrally, the team will support the Ministry of Health with the Ministry of Finance on programmatic budgeting including questions of budgetary flexibility and implementation of prospective budget reviews to support the ministry in dealing with budget cuts and to better align the budget to the MoH objectives. This will complement planned work by CHAI and a USAID contractor. The team will also work with the Ministries of Health and Finance to develop new modules on programmatic and priority-based budgeting for the annual training of district medical officers. This training is supported by the WB-financed PRSS operation and all future ministry management staff go through this training program. Therefore, the training will has the potential to have downstream impacts beyond the initial training.



There is the potential to also provide support to the Ministry of Health to better allocate human resources with the newly-developed human resource database and the Workload Indicative Staffing Needs information. This is closely linked to the ongoing Development Policy Financing?s measure to strengthen human resources in rural areas. The team has identified as an additional possible reform measure that requires technical assistance to develop tools to help ministry staff to better understand their human and material resources to adjust allocations.">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Work program is progressing with delays to due to COVID-19.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">AMP : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Reporting is submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assessing and reporting  against agreed indicators">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The pilot for the application (proof of concept) is carried out</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identification of specific features needing to be taken into account to adapt ERILE to the Burkina Faso context and adaptation of the application by AMP?s contractor accordingly in the pilot districts, proof of concept and field pilot">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Project implementation is carried out</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementation: preparatory meetings, contractualization of sites, social mobilization and publication; Deployment of immunization services and application to all sites">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; The situational analysis is carried out</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Situational analysis at the level of public and private health facilities and the target public (including mapping of pilot districts and sites of sustainable advanced strategies)">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Finalized project document</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Project development">
      <location ref="BF"></location>
     </target>
     <actual>
      <location ref="BF"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Project development">
      <location ref="BF"></location>
     </target>
     <actual>
      <location ref="BF"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; Swift resolution of issues arising for the roll out of the project in the agreed timeframe.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Situational analysis at the level of public and private health facilities and the target public (including mapping of pilot districts and sites of sustainable advanced strategies)">
      <location ref="BF"></location>
     </target>
     <actual>
      <location ref="BF"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Situational analysis at the level of public and private health facilities and the target public (including mapping of pilot districts and sites of sustainable advanced strategies)">
      <location ref="BF"></location>
     </target>
     <actual>
      <location ref="BF"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">PPAc 2021-2025 est valid&#xE9; et disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration du PPAc 2021-2025">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les pr&#xE9;paratifs sont en cours pour l?&#xE9;valuation du PPAc 20216-2020 dont les r&#xE9;sultats serviront pour l?&#xE9;laboration de la strat&#xE9;gie nationale de vaccination qui remplacera le PPAC</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration du PPAc 2021-2025">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">Les pr&#xE9;paratifs sont en cours pour l?&#xE9;valuation du PPAc 20216-2020 dont les r&#xE9;sultats serviront pour l?&#xE9;laboration de la strat&#xE9;gie nationale de vaccination qui remplacera le PPAC</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Raport de revue du deuxieme semestre disponi</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la revue semestrielle du programme">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">la tenue des revue ont permis aux acteurs du PEV et les partenaires techniques et financiers de de faire une mise &#xE0; jour des connaissances des diff&#xE9;rents acteurs sur la vaccination et la surveillance des MEV, de r&#xE9;aliser une retro-information des donn&#xE9;es de la vaccination et les maladies &#xE9;vitables par la vaccination , de r&#xE9;aliser une partage de bonnes pratiques entre les diff&#xE9;rents acteurs du PEV , d?identifier les difficult&#xE9;s li&#xE9;es &#xE0; la mise en ?uvre des activit&#xE9;s de vaccination et de la surveillance des maladies &#xE9;vitables par la vaccination et de formuler des recommandations pour am&#xE9;liorer l?efficacit&#xE9; du programme.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la revue semestrielle du programme">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">la tenue des revue ont permis aux acteurs du PEV et les partenaires techniques et financiers de de faire une mise &#xE0; jour des connaissances des diff&#xE9;rents acteurs sur la vaccination et la surveillance des MEV, de r&#xE9;aliser une retro-information des donn&#xE9;es de la vaccination et les maladies &#xE9;vitables par la vaccination , de r&#xE9;aliser une partage de bonnes pratiques entre les diff&#xE9;rents acteurs du PEV , d?identifier les difficult&#xE9;s li&#xE9;es &#xE0; la mise en ?uvre des activit&#xE9;s de vaccination et de la surveillance des maladies &#xE9;vitables par la vaccination et de formuler des recommandations pour am&#xE9;liorer l?efficacit&#xE9; du programme.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le premier draft du PPAc 2021-2025 disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration du PPAc 2021-2025">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">le PPAc 2016-2020 sera &#xE9;valu&#xE9; et la strat&#xE9;gie nationale de la vaccination dans le cadre de l?Agenda de la vaccination 2030 sera &#xE9;laborerez en lieux place de du PPAc 2021-2025</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Au moins 50% des recommandations de la revue du PEV sont mises en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la revue approfondie du PEV en 2019">
      <location ref="BF"></location>
     </target>
     <actual value="Completed">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">la revue approfondie du PEV a &#xE9;t&#xE9; r&#xE9;alis&#xE9; &#xE0; travers les diff&#xE9;rentes &#xE9;tapes recommand&#xE9;es pour la revue approfondie du programme &#xE9;largi de vaccination : la revue documentaire &#xE9;t&#xE9; r&#xE9;alis&#xE9;e et compl&#xE9;t&#xE9;e avec les enqu&#xEA;tes terrain. Aussi l?analyse des donn&#xE9;es est faite. La r&#xE9;daction du rapport g&#xE9;n&#xE9;ral est en cours ainsi que l?&#xE9;laboration de la feuille de route.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les TDR du consultant international sont &#xE9;labor&#xE9;s et le consultant est recrut&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration du PPAc 2021-2025">
      <location ref="BF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">le PPAc 2016-2020 sera &#xE9;valu&#xE9; et la strat&#xE9;gie nationale de la vaccination dans le cadre de l?Agenda de la vaccination 2030 sera &#xE9;laborerez en lieux place de du PPAc 2021-2025. La non disponibilit&#xE9; du guide de r&#xE9;f&#xE9;rence pour l?&#xE9;laboration de la strat&#xE9;gie nationale de vaccination dans le cadre de l?Agenda de la vaccination 2030 retarde la mise en ?uvre de l?activit&#xE9;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned)
8. Scorecard app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="BF"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">HISP WCA continues to remind the country to send EPI legacy that has to be imported. 
Scorecard app installed. Country to confirm meeting arrangements for configuration</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="BF"></location>
     </target>
     <actual value="On Track">
      <location ref="BF"></location>
      <comment>
       <narrative xml:lang="EN">PAckage installed by the country, HISP WCA working on interoperability with Vigibase now. Hence it is completed but still working on it.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned) 8. Scorecard app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="BF"></location>
     </target>
     <actual>
      <location ref="BF"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on planned digital data package or app and know how to use it
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="BF"></location>
     </target>
     <actual>
      <location ref="BF"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="BF"></location>
     </target>
     <actual>
      <location ref="BF"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
